Revolution Medicines (RVMD) Leases: 2020-2025
Historic Leases for Revolution Medicines (RVMD) over the last 6 years, with Sep 2025 value amounting to $134.4 million.
- Revolution Medicines' Leases rose 80.86% to $134.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $134.4 million, marking a year-over-year increase of 80.86%. This contributed to the annual value of $117.5 million for FY2024, which is 52.35% up from last year.
- Latest data reveals that Revolution Medicines reported Leases of $134.4 million as of Q3 2025, which was up 17.94% from $114.0 million recorded in Q2 2025.
- Over the past 5 years, Revolution Medicines' Leases peaked at $134.4 million during Q3 2025, and registered a low of $25.0 million during Q1 2023.
- Moreover, its 3-year median value for Leases was $76.2 million (2024), whereas its average is $83.3 million.
- In the last 5 years, Revolution Medicines' Leases soared by 215.25% in 2021 and then slumped by 57.32% in 2023.
- Quarterly analysis of 5 years shows Revolution Medicines' Leases stood at $59.7 million in 2021, then declined by 7.73% to $55.1 million in 2022, then spiked by 40.07% to $77.1 million in 2023, then skyrocketed by 52.35% to $117.5 million in 2024, then spiked by 80.86% to $134.4 million in 2025.
- Its last three reported values are $134.4 million in Q3 2025, $114.0 million for Q2 2025, and $115.8 million during Q1 2025.